265 related articles for article (PubMed ID: 18322250)
1. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century.
Pulte D; Gondos A; Brenner H
Haematologica; 2008 Apr; 93(4):594-600. PubMed ID: 18322250
[TBL] [Abstract][Full Text] [Related]
2. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
3. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century.
Pulte D; Gondos A; Brenner H
Arch Intern Med; 2008 Mar; 168(5):469-76. PubMed ID: 18332290
[TBL] [Abstract][Full Text] [Related]
4. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.
Kristinsson SY; Landgren O; Dickman PW; Derolf AR; Björkholm M
J Clin Oncol; 2007 May; 25(15):1993-9. PubMed ID: 17420512
[TBL] [Abstract][Full Text] [Related]
5. Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level.
Brenner H; Gondos A; Pulte D
Haematologica; 2008 Oct; 93(10):1544-9. PubMed ID: 18641022
[TBL] [Abstract][Full Text] [Related]
6. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis.
Brenner H; Gondos A; Arndt V
J Clin Oncol; 2007 Aug; 25(22):3274-80. PubMed ID: 17664474
[TBL] [Abstract][Full Text] [Related]
7. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
Pulte D; Gondos A; Brenner H
Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and quality of care in acute myeloid leukemia over 40 years.
Alibhai SM; Leach M; Minden MD; Brandwein J
Cancer; 2009 Jul; 115(13):2903-11. PubMed ID: 19452536
[TBL] [Abstract][Full Text] [Related]
9. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
10. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
Brenner H; Arndt V
J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
[TBL] [Abstract][Full Text] [Related]
12. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
13. Improved survival among children with acute leukemia diagnosed in the 1970s.
Steinhorn SC
Cancer Treat Rep; 1984; 68(7-8):953-8. PubMed ID: 6744345
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
15. Survival expectations of patients diagnosed with Hodgkin's lymphoma in 2006-2010.
Brenner H; Gondos A; Pulte D
Oncologist; 2009 Aug; 14(8):806-13. PubMed ID: 19648314
[TBL] [Abstract][Full Text] [Related]
16. Relative lack of conditional survival improvement in young adults with cancer.
Bleyer A; Choi M; Fuller CD; Thomas CR; Wang SJ
Semin Oncol; 2009 Oct; 36(5):460-7. PubMed ID: 19835741
[TBL] [Abstract][Full Text] [Related]
17. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.
Sultan I; Qaddoumi I; Yaser S; Rodriguez-Galindo C; Ferrari A
J Clin Oncol; 2009 Jul; 27(20):3391-7. PubMed ID: 19398574
[TBL] [Abstract][Full Text] [Related]
18. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R
Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545
[TBL] [Abstract][Full Text] [Related]
19. Acute leukemia in patients sixty years of age and older: a twenty year single institution review.
Leger CS; Leitch HA; Galbraith PF; Li CH; Vickars LM
Am J Clin Oncol; 2009 Apr; 32(2):137-41. PubMed ID: 19307947
[TBL] [Abstract][Full Text] [Related]
20. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
Cheema PK; Zadeh S; Kukreti V; Reece D; Chen C; Trudel S; Mikhael J
Biol Blood Marrow Transplant; 2009 Jun; 15(6):686-93. PubMed ID: 19450753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
